Editorial: Hallmark of cancer: avoiding immune suppression

Front Oncol. 2023 Jun 16:13:1211456. doi: 10.3389/fonc.2023.1211456. eCollection 2023.

Authors

Faris Q B Alenzi¹, Benedetta Apollonio², Liusheng Peng³, Elias J Sayour⁴, Michal Sheffer⁵

Affiliations

¹ Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
² S.S.D. Rare Tumors and Melanoma, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
³ Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China.
⁴ Department of Neurosurgery, University of Florida, Gainesville, FL, United States.
⁵ Dana-Farber Cancer Institute, Boston, MA, United States.

No abstract available

Keywords: cancer immunotherapy; immunosuppression; metabolomics; prediction; tumor microenvironment.

Publication types

Editorial